Hi - I've been away for a little while and realised I forgot to say thank you 
for all the valuable comments on the subject of stereochemistry depicting!

 

Thanks.

 
> From: [email protected]
> Date: Wed, 10 Jun 2009 20:00:54 +0200
> To: [email protected]
> CC: [email protected]
> Subject: Re: [Rdkit-discuss] BEGINWEDGE and BEGINDASH
> 
> On Wed, Jun 10, 2009 at 5:27 PM, Igor Filippov<[email protected]> 
> wrote:
> >
> >> Igor, as you said, you spend a lot of time thinking about this stuff:
> >> what would you say the general rule is?
> >>
> >> -greg
> >
> > Oh, I'm certainly not getting into a flame war about the correct way to
> > depict stereochemistry!!! :) I've seen people far more knowledgeable
> > than me having arguments about this until these days at the InChI
> > steering committee meeting. This is probably an argument that has been
> > going on for decades with no resolution.
> 
> Ah, you're no fun. ;-)
> 
> > input drawing as closely as possible. So for me the best resolution
> > would be to allow the programmer (in python or c++) to create the
> > molecular object the way he sees fit and not to force him to adhere to
> > an arbitrary limitation.
> 
> Agreed. And this is how the RDKit handles it: if you use
> WedgeMolBonds() it does things "my" way (=one wedged bond per chiral
> center), but you are always free to add additional wedging in your own
> code.
> 
> -greg
> 
> ------------------------------------------------------------------------------
> Crystal Reports - New Free Runtime and 30 Day Trial
> Check out the new simplified licensing option that enables unlimited
> royalty-free distribution of the report engine for externally facing 
> server and web deployment.
> http://p.sf.net/sfu/businessobjects
> _______________________________________________
> Rdkit-discuss mailing list
> [email protected]
> https://lists.sourceforge.net/lists/listinfo/rdkit-discuss

_________________________________________________________________
Get the best of MSN on your mobile
http://clk.atdmt.com/UKM/go/147991039/direct/01/

Reply via email to